Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology. | Cancer Metastasis Rev | 2022 | 34716856 | PubTator, text mining | PubMed |
| Targeting adipocytic discoidin domain receptor 2 impedes fat gain while increasing bone mass. | Cell Death Differ | 2022 | 34645939 | PubTator, text mining | PubMed |
| Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence. | Int J Gynecol Pathol | 2022 | 34483300 | PubTator, text mining | PubMed |
| Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma. | Haematologica | 2022 | 34382383 | PubTator, text mining | PubMed |
| Current and future applications of biomarkers in samples collected through minimally invasive methods for cancer medicine and population-based research. | Am J Hum Biol | 2022 | 34374148 | PubTator, text mining | PubMed |
| Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes. | Cancer Immunol Immunother | 2022 | 34228218 | PubTator, text mining | PubMed |
| Germline BRCA2 mutation in a case of aggressive prostate cancer accompanied by spinal bulbar muscular atrophy. | Asian J Androl | 2022 | 34045389 | PubTator, text mining | PubMed |
| 3-Nitrobenzanthrone promotes malignant transformation in human lung epithelial cells through the epiregulin-signaling pathway. | Cell Biol Toxicol | 2022 | 34036453 | PubTator, text mining | PubMed |
| Generation of Quiescent Cardiac Fibroblasts Derived from Human Induced Pluripotent Stem Cells. | Methods Mol Biol | 2022 | 32671814 | PubTator, text mining | PubMed |
| Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type. | Explor Target Antitumor Ther | 2021 | 36046437 | PubTator, text mining | PubMed |
| Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma. | Explor Target Antitumor Ther | 2021 | 36046090 | PubTator, text mining | PubMed |
| Current progress, challenges and future prospects of indazoles as protein kinase inhibitors for the treatment of cancer. | RSC Adv | 2021 | 35478899 | PubTator, text mining | PubMed |
| Retroperitoneal Liposarcoma: An Unusual Presentation of a Rare Cancer. | J Adv Pract Oncol | 2021 | 35295543 | PubTator, text mining | PubMed |
| Identifying Actionable Variants Using Capture-Based Targeted Sequencing in 563 Patients With Non-Small Cell Lung Carcinoma. | Front Oncol | 2021 | 35186718 | PubTator, text mining | PubMed |
| Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm. | Ther Adv Endocrinol Metab | 2021 | 35154635 | PubTator, text mining | PubMed |
| Systematically integrative analysis identifies diagnostic and prognostic candidates and small-molecule drugs for lung adenocarcinoma. | Transl Cancer Res | 2021 | 35116665 | PubTator, text mining | PubMed |
| Emerging Role and Mechanism of circRNAs in Pediatric Malignant Solid Tumors. | Front Genet | 2021 | 35116058 | PubTator, text mining | PubMed |
Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A). | Front Genet | 2021 | 35116055 | PubTator, text mining | PubMed |
| Cartilage Tissue Engineering Approaches Need to Assess Fibrocartilage When Hydrogel Constructs Are Mechanically Loaded. | Front Bioeng Biotechnol | 2021 | 35096790 | PubTator, text mining | PubMed |
| LncRNAs and Rheumatoid Arthritis: From Identifying Mechanisms to Clinical Investigation. | Front Immunol | 2021 | 35087527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=37